Simplex Trading’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Simplex Trading’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-474	Closed	-$84K	–	7187
2016 Q3	$84K	Sell	474 -94	-17%	-$16.7K	0.01%	1678
2016 Q2	$71K	Buy	568 +344	+154%	+$43K	﹤0.01%	1742
2016 Q1	$34K	Buy	224 +110	+96%	+$16.7K	﹤0.01%	2330
2015 Q4	$24K	Buy	114 +80	+235%	+$16.8K	﹤0.01%	2555
2015 Q3	$17K	Buy	34 +20	+143%	+$10K	﹤0.01%	2993
2015 Q2	$6K	Sell	14 -17	-55%	-$7.29K	﹤0.01%	3614
2015 Q1	$10K	Sell	31 -148	-83%	-$47.7K	﹤0.01%	2991
2014 Q4	$22K	Buy	+179	New	+$22K	﹤0.01%	1992

Simplex Trading's RXII Position: Q4 2016 in Review

Simplex Trading sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 18,771 shares — an estimated $6K sold.

Simplex Trading first reported a position in RXII in Q3 2015 and held it in 5 quarters. The position peaked at $21K in Q2 2016. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

Simplex Trading reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
Simplex Trading sold 18,771 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $6K.
Simplex Trading first reported a position in GALENA BIOPHARMA INC COM in Q3 2015 and held it in 5 quarters.
Simplex Trading's GALENA BIOPHARMA INC COM position peaked at $21K in Q2 2016.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Simplex Trading's 13F filing for Q4 2016, filed 11 Jan 2017.